查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1592004

体外诊断品管市场：按产品、分销商、应用和最终用户划分 - 2025-2030 年全球预测

In-Vitro Diagnostics Quality Control Market by Offering (Data Management Solutions, Quality Assurance Services, Quality Control Products), Distributor (OEM, Third-Party Control Manufacturers), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

体外诊断试剂品管市场规模预计2023年为13.7亿美元，预计2024年将达14.8亿美元，复合年增长率为8.34%，2030年将达24.1亿美元。

体外诊断 (IVD)品管是指用于确保在体外进行的诊断测试（例如血液测试和其他实验室分析）的准确性和可靠性的流程和材料。这个市场的需求在于它在确保测试准确性、减少误报和漏报以及确保遵守严格的监管标准方面发挥关键作用。研究应用范围广泛，包括临床实验室、医院、学术和研究机构，最终用途包括监测疾病进展、诊断医疗状况和管理药物治疗。主要成长动力包括慢性病的增加、实验室自动化程度的提高以及就地检验的普及。最近的技术创新，例如将人工智慧整合到分子诊断和品管过程中，提供了新的机会，特别是随着个人化医疗需求的增加。为了利用这些机会，公司需要投资研发，为现有和新兴的诊断平台开发更复杂、更具适应性的品管解决方案。然而，市场面临一定的限制和挑战，例如与品管产品相关的高成本、监管障碍以及不同诊断设备之间缺乏标准化。这些挑战可能会给中小企业造成进入障碍并阻碍市场成长。儘管存在这些挑战，为了提高市场渗透率，创新应特别关注具有成本效益的解决方案以及不同製造商设备之间的互通性。总体而言，体外诊断品管市场的特点是技术快速进步和严格监督，要求企业不断适应和创新以保持竞争力。有针对性的研发投资以及策略联盟和收购可以进一步推动成长并增加这个充满活力和不断发展的行业的市场份额。

主要市场统计
基准年[2023] 13.7亿美元
预测年份 [2024] 14.8亿美元
预测年份 [2030] 24.1亿美元
复合年增长率（%） 8.34%

市场动态：快速发展的体外诊断品管市场的关键市场洞察

供需的动态交互作用正在改变体外诊断的品管市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 慢性病和感染疾病的流行以及体外诊断的需求
    • 对照护现场诊断技术和第三方品管的需求不断增长
    • 确保诊断设备和服务安全的政府法规
  • 市场限制因素
    • IVD品管服务成本高
  • 市场机会
    • 将智慧品管引入体外诊断药物的研发活动
    • 硅技术与多项控制技术进步
  • 市场挑战
    • 体外诊断药物核准的严格规定与不准确之处

波特五力：驾驭体外诊断品管市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解体外诊断试剂品管市场的外部影响

外部宏观环境因素在塑造体外诊断品管市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解体外诊断试剂品管市场的竞争状况

对体外诊断品管市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵体外诊断品管市场供应商绩效评估

FPNV 定位矩阵是评估体外诊断品管市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议 规划 IVD品管市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，体外诊断品管市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病和感染疾病的流行以及体外诊断的需求
      • 对照护现场诊断技术和第三方品管的需求不断增长
      • 确保诊断设备和服务安全的政府法规
    • 抑制因素
      • IVD品管服务高成本
    • 机会
      • 旨在为体外诊断引入智慧品管的研发活动
      • 硅技术和多分析物控制的技术进步
    • 任务
      • 体外诊断检测产品核准的严格规定及不准确问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章体外诊断品管市场：透过提供

  • 资料管理解决方案
  • 品质保证服务
  • 品管产品
    • 基于血清/血浆的控制
    • 尿液检查
    • 基于全血的控制

第七章 体外诊断试剂品管市场（依供应商划分）

  • 製造商
  • 第三方控制厂商
    • 由独立製造商管理
    • 仪器特定控制

第八章体外诊断品管市场：依应用分类

  • 临床化学
  • 凝血或止血
  • 血液学
  • 免疫化学
  • 微生物学
  • 分子诊断

第九章 体外诊断试剂品管市场：依最终用户分类

  • 临床实验室
  • 医院
  • 研究/学术机构

第十章 南北美洲体外诊断试剂品管市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太体外诊断品管市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东、非洲体外诊断试剂品管市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 印度子公司获得ISO13485认证
    • Werfen 完成对 Immucor 的收购
    • EDX 完成对 IVD 产品开发商 Torax Biosciences 的收购
    • 西门子 Healthineers 和 Unilab 开始建立策略合作伙伴关係，共同建造最先进的诊断测试基础设施，以改善患者照护
    • UL 解决方案扩大了体外诊断的范围
    • Qiagen 推出用于实验室自动采样的 IVD 平台
    • InDevR 筹集 900 万美元 B 轮资金筹措并与生物梅里埃合作
    • Veranex 收购 Devicia 和 Clarvin，以扩大 IVD 和医疗设备监管、品质和临床专业知识
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • bioMerieux Inc.
  • CalibreScientific Global Distribution, Inc.
  • Danaher Corporation
  • Devyser AB
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd.
  • Fortress Diagnostics
  • Grifols, SA
  • Hologic, Inc.
  • Illumina, Inc.
  • LGC Limited
  • Maine Molecular Quality Controls, Inc.
  • Micro Bio Logics, Inc.
  • Microbix Biosystems Inc.
  • Ortho-Clinical Diagnostics, Inc.
  • Qiagen NV
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Seegene Inc.
  • Siemens AG
  • Streck, Inc.
  • Sun Diagnostics, LLC
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • ZeptoMetrix Corporation
Product Code: MRR-43127F7279E1

The In-Vitro Diagnostics Quality Control Market was valued at USD 1.37 billion in 2023, expected to reach USD 1.48 billion in 2024, and is projected to grow at a CAGR of 8.34%, to USD 2.41 billion by 2030.

In-Vitro Diagnostics (IVD) Quality Control refers to the processes and materials used to ensure accuracy and reliability in diagnostic tests performed outside the living body, such as blood tests and other lab analyses. This market's necessity lies in the critical role it plays in ensuring test accuracy, reducing false positives/negatives, and ensuring compliance with stringent regulatory standards. Applications range across clinical laboratories, hospitals, and academic/research institutions, with an end-use scope extending to monitoring disease progression, diagnosis of medical conditions, and drug therapy management. Key growth drivers include the increasing prevalence of chronic diseases, advancements in laboratory automation, and growing adoption of point-of-care testing. Recent technological innovations like molecular diagnostics and the integration of artificial intelligence in quality control processes offer fresh opportunities, especially as the demand for personalized medicine grows. To capitalize on these opportunities, companies should invest in R&D to develop more sophisticated, adaptive quality control solutions that address both existing and emerging diagnostic platforms. Nevertheless, the market faces certain limitations and challenges, including high costs associated with quality control products, regulatory hurdles, and a lack of standardization across different diagnostic devices. These challenges can hinder market growth by creating barriers to entry for smaller players. Despite these challenges, innovation should particularly focus on cost-effective solutions and interoperability between devices from different manufacturers to enhance market penetration. Overall, the IVD quality control market is characterized by rapid technological advancements and stringent oversight, requiring players to continuously adapt and innovate to maintain their competitive edge. Investment in targeted R&D, coupled with strategic partnerships and acquisitions, can further drive growth and increase market presence in this dynamic and evolving sector.

KEY MARKET STATISTICS
Base Year [2023] USD 1.37 billion
Estimated Year [2024] USD 1.48 billion
Forecast Year [2030] USD 2.41 billion
CAGR (%) 8.34%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving In-Vitro Diagnostics Quality Control Market

The In-Vitro Diagnostics Quality Control Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic and infectious diseases and need for in-vitro diagnostics
    • Growing demand for point-of-care diagnostic technologies and third-party quality controls
    • Government regulations to ensure the safety of diagnostics devices and services
  • Market Restraints
    • High cost of IVD quality control services
  • Market Opportunities
    • R&D activities to introduce smart quality control for in-vitro diagnostics
    • Technological advancement in silicon technology and multianalyte controls
  • Market Challenges
    • Stringent regulations for approval of IVD test products and inaccuracy issues

Porter's Five Forces: A Strategic Tool for Navigating the In-Vitro Diagnostics Quality Control Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the In-Vitro Diagnostics Quality Control Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the In-Vitro Diagnostics Quality Control Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the In-Vitro Diagnostics Quality Control Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the In-Vitro Diagnostics Quality Control Market

A detailed market share analysis in the In-Vitro Diagnostics Quality Control Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the In-Vitro Diagnostics Quality Control Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the In-Vitro Diagnostics Quality Control Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the In-Vitro Diagnostics Quality Control Market

A strategic analysis of the In-Vitro Diagnostics Quality Control Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the In-Vitro Diagnostics Quality Control Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMerieux Inc., CalibreScientific Global Distribution, Inc., Danaher Corporation, Devyser AB, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Fortress Diagnostics, Grifols, S.A., Hologic, Inc., Illumina, Inc., LGC Limited, Maine Molecular Quality Controls, Inc., Micro Bio Logics, Inc., Microbix Biosystems Inc., Ortho-Clinical Diagnostics, Inc., Qiagen N.V., Quidel Corporation, Randox Laboratories Ltd., Seegene Inc., Siemens AG, Streck, Inc., Sun Diagnostics, LLC, Sysmex Corporation, Thermo Fisher Scientific, Inc., and ZeptoMetrix Corporation.

Market Segmentation & Coverage

This research report categorizes the In-Vitro Diagnostics Quality Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Data Management Solutions, Quality Assurance Services, and Quality Control Products. The Quality Control Products is further studied across Serum/Plasma-Based Controls, Urine-Based Controls, and Whole-Blood-Based Controls.
  • Based on Distributor, market is studied across OEM and Third-Party Control Manufacturers. The Third-Party Control Manufacturers is further studied across Independent Manufacturer Controls and Instrument-Specific Controls.
  • Based on Application, market is studied across Clinical Chemistry, Coagulation or Hemostasis, Hematology, Immunochemistry, Microbiology, and Molecular Diagnostics.
  • Based on End-User, market is studied across Clinical Laboratories, Hospitals, and Research & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic and infectious diseases and need for in-vitro diagnostics
      • 5.1.1.2. Growing demand for point-of-care diagnostic technologies and third-party quality controls
      • 5.1.1.3. Government regulations to ensure the safety of diagnostics devices and services
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of IVD quality control services
    • 5.1.3. Opportunities
      • 5.1.3.1. R&D activities to introduce smart quality control for in-vitro diagnostics
      • 5.1.3.2. Technological advancement in silicon technology and multianalyte controls
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations for approval of IVD test products and inaccuracy issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. In-Vitro Diagnostics Quality Control Market, by Offering

  • 6.1. Introduction
  • 6.2. Data Management Solutions
  • 6.3. Quality Assurance Services
  • 6.4. Quality Control Products
    • 6.4.1. Serum/Plasma-Based Controls
    • 6.4.2. Urine-Based Controls
    • 6.4.3. Whole-Blood-Based Controls

7. In-Vitro Diagnostics Quality Control Market, by Distributor

  • 7.1. Introduction
  • 7.2. OEM
  • 7.3. Third-Party Control Manufacturers
    • 7.3.1. Independent Manufacturer Controls
    • 7.3.2. Instrument-Specific Controls

8. In-Vitro Diagnostics Quality Control Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Chemistry
  • 8.3. Coagulation or Hemostasis
  • 8.4. Hematology
  • 8.5. Immunochemistry
  • 8.6. Microbiology
  • 8.7. Molecular Diagnostics

9. In-Vitro Diagnostics Quality Control Market, by End-User

  • 9.1. Introduction
  • 9.2. Clinical Laboratories
  • 9.3. Hospitals
  • 9.4. Research & Academic Institutes

10. Americas In-Vitro Diagnostics Quality Control Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific In-Vitro Diagnostics Quality Control Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa In-Vitro Diagnostics Quality Control Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Indian Subsidiary Acquires ISO13485 Certification
    • 13.3.2. Werfen Completes Acquisition of Immucor
    • 13.3.3. EDX Completes Acquisition of IVD Products Developer Torax Biosciences
    • 13.3.4. Siemens Healthineers and Unilabs Launch Strategic Partnership For Latest Diagnostic Testing Infrastructure To Improve Patients' Care
    • 13.3.5. UL Solutions Expands Scope For In Vitro Diagnostics
    • 13.3.6. Qiagen Unveils IVD Platform For Automated Sampling In Laboratories
    • 13.3.7. InDevR Raises $9 Million in Series B Financing and Partners with bioMerieux
    • 13.3.8. Veranex Acquires Devicia and Clarvin, Expanding Regulatory, Quality, and Clinical Expertise for IVD and Medical Devices
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Bio-Techne Corporation
  • 6. bioMerieux Inc.
  • 7. CalibreScientific Global Distribution, Inc.
  • 8. Danaher Corporation
  • 9. Devyser AB
  • 10. DiaSorin S.p.A.
  • 11. F. Hoffmann-La Roche Ltd.
  • 12. Fortress Diagnostics
  • 13. Grifols, S.A.
  • 14. Hologic, Inc.
  • 15. Illumina, Inc.
  • 16. LGC Limited
  • 17. Maine Molecular Quality Controls, Inc.
  • 18. Micro Bio Logics, Inc.
  • 19. Microbix Biosystems Inc.
  • 20. Ortho-Clinical Diagnostics, Inc.
  • 21. Qiagen N.V.
  • 22. Quidel Corporation
  • 23. Randox Laboratories Ltd.
  • 24. Seegene Inc.
  • 25. Siemens AG
  • 26. Streck, Inc.
  • 27. Sun Diagnostics, LLC
  • 28. Sysmex Corporation
  • 29. Thermo Fisher Scientific, Inc.
  • 30. ZeptoMetrix Corporation

LIST OF FIGURES

  • FIGURE 1. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET RESEARCH PROCESS
  • FIGURE 2. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET DYNAMICS
  • TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY ASSURANCE SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SERUM/PLASMA-BASED CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY URINE-BASED CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT MANUFACTURER CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INSTRUMENT-SPECIFIC CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COAGULATION OR HEMOSTASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 283. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, FPNV POSITIONING MATRIX, 2023